Background Cannabis legalization has enabled increased consumption in older adults. Age-
related mental, physical, and physiological changes may lead to differences in effects of …

Objectives Cannabis-based medicinal products (CBMPs) have shown promising preclinical
activity in inflammatory bowel disease (IBD). However, clinical trials have not demonstrated …

Background Although studied in a few randomized controlled trials, the efficacy of medical
cannabis (MC) for chronic pain remains controversial. Using an alternative approach, this …

Objectives To explore pain-specific, general health-related quality of life (HRQoL), and
safety outcomes of chronic pain patients prescribed cannabis-based medicinal products …

Abstract Study Objectives We conducted a systematic review to explore the effectiveness of
medical cannabis for impaired sleep. Methods We searched MEDLINE, EMBASE …

Cannabis use and interest continues to increase among patients with cancer and
caregivers. High-quality research remains scant in many areas, causing hesitancy or …

The use of cannabis products to help with sleep and various other medical conditions by the
public has increased significantly in recent years. Withdrawal from cannabinoids can lead to …

Introduction: Cannabis-based medicinal products (CBMPs) have been identified as a
promising novel therapeutic for symptoms and comorbidities related to autism spectrum …

Introduction Cannabis is used for medical and recreational purposes and may result in
cannabis use disorder (CUD). This study explored the prevalence of cannabis use disorder …

Background: Utilizing cannabis as a therapeutic option for chronic pain (CP) has increased
significantly. However, data regarding the potential immunomodulatory effects of cannabis in …